Acceleron Pharma (XLRN) Earnings
|
Expand Research on XLRN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/5/21 |  |
Q221 | -$0.81 | -$0.88 | +$0.07 | $27.94M | $33.44M | N/A |  | | Details |
| 5/6/21 | |
Q121 | -$0.77 | -$0.81 | +$0.04 | $24.76M | $28.89M | N/A | | | Details |
| 2/25/21 | |
Q420 | -$0.95 | -$0.59 | -$0.36 | $25.87M | $32.31M | N/A | | | Details |
11/5/20  |
|
Q320 | N/A | -$0.61 | N/A | N/A | $26.27M | N/A | N/A | N/A | |
| 8/6/20 | |
Q220 | -$0.34 | -$0.57 | +$0.23 | $39.75M | $30.08M | N/A | | | Details |
| 5/11/20 | |
Q120 | -$0.95 | -$0.86 | -$0.09 | N/A | $5.26M | N/A | | | Details |
| 2/27/20 | |
Q419 | -$0.44 | -$0.30 | -$0.14 | $39.34M | $35.89M | N/A | | | Details |
| 11/6/19 | |
Q319 | -$0.86 | -$0.82 | -$0.04 | $4.21M | $4.44M | N/A | | | Details |
